GO:0048518 | positive regulation of biological process | 48.15% (52/108) | 1.48 | 0.0 | 0.0 |
GO:0016192 | vesicle-mediated transport | 19.44% (21/108) | 2.89 | 0.0 | 0.0 |
GO:0051641 | cellular localization | 27.78% (30/108) | 2.23 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 62.04% (67/108) | 1.09 | 0.0 | 0.0 |
GO:0048523 | negative regulation of cellular process | 37.04% (40/108) | 1.73 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 37.96% (41/108) | 1.62 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 89.81% (97/108) | 0.56 | 0.0 | 0.0 |
GO:0048193 | Golgi vesicle transport | 12.04% (13/108) | 3.67 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 88.89% (96/108) | 0.56 | 0.0 | 0.0 |
GO:0051179 | localization | 38.89% (42/108) | 1.54 | 0.0 | 0.0 |
GO:0005515 | protein binding | 69.44% (75/108) | 0.87 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 67.59% (73/108) | 0.88 | 0.0 | 0.0 |
GO:0051128 | regulation of cellular component organization | 25.0% (27/108) | 2.11 | 0.0 | 0.0 |
GO:0048522 | positive regulation of cellular process | 38.89% (42/108) | 1.49 | 0.0 | 0.0 |
GO:0005488 | binding | 79.63% (86/108) | 0.67 | 0.0 | 0.0 |
GO:0043226 | organelle | 70.37% (76/108) | 0.81 | 0.0 | 0.0 |
GO:0016482 | cytosolic transport | 8.33% (9/108) | 4.46 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 62.96% (68/108) | 0.91 | 0.0 | 0.0 |
GO:0023051 | regulation of signaling | 27.78% (30/108) | 1.84 | 0.0 | 0.0 |
GO:0010646 | regulation of cell communication | 27.78% (30/108) | 1.83 | 0.0 | 0.0 |
GO:0031982 | vesicle | 24.07% (26/108) | 2.03 | 0.0 | 0.0 |
GO:0046907 | intracellular transport | 18.52% (20/108) | 2.42 | 0.0 | 0.0 |
GO:0031410 | cytoplasmic vesicle | 22.22% (24/108) | 2.09 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 68.52% (74/108) | 0.78 | 0.0 | 0.0 |
GO:0051234 | establishment of localization | 33.33% (36/108) | 1.52 | 0.0 | 0.0 |
GO:0097708 | intracellular vesicle | 22.22% (24/108) | 2.05 | 0.0 | 0.0 |
GO:0048519 | negative regulation of biological process | 38.89% (42/108) | 1.34 | 0.0 | 0.0 |
GO:0006810 | transport | 32.41% (35/108) | 1.55 | 0.0 | 0.0 |
GO:0005829 | cytosol | 37.04% (40/108) | 1.38 | 0.0 | 0.0 |
GO:0033043 | regulation of organelle organization | 14.81% (16/108) | 2.64 | 0.0 | 1e-06 |
GO:0070727 | cellular macromolecule localization | 20.37% (22/108) | 2.1 | 0.0 | 1e-06 |
GO:1902494 | catalytic complex | 20.37% (22/108) | 2.07 | 0.0 | 1e-06 |
GO:0051649 | establishment of localization in cell | 18.52% (20/108) | 2.19 | 0.0 | 1e-06 |
GO:0008104 | protein localization | 18.52% (20/108) | 2.12 | 0.0 | 2e-06 |
GO:0032879 | regulation of localization | 19.44% (21/108) | 2.02 | 0.0 | 3e-06 |
GO:0009966 | regulation of signal transduction | 24.07% (26/108) | 1.74 | 0.0 | 3e-06 |
GO:0006996 | organelle organization | 25.0% (27/108) | 1.68 | 0.0 | 3e-06 |
GO:0033036 | macromolecule localization | 20.37% (22/108) | 1.94 | 0.0 | 3e-06 |
GO:0008150 | biological_process | 85.19% (92/108) | 0.47 | 0.0 | 5e-06 |
GO:0071840 | cellular component organization or biogenesis | 38.89% (42/108) | 1.16 | 0.0 | 7e-06 |
GO:0051049 | regulation of transport | 16.67% (18/108) | 2.1 | 0.0 | 1.3e-05 |
GO:0005768 | endosome | 15.74% (17/108) | 2.17 | 0.0 | 1.5e-05 |
GO:0045184 | establishment of protein localization | 14.81% (16/108) | 2.26 | 0.0 | 1.6e-05 |
GO:0060627 | regulation of vesicle-mediated transport | 9.26% (10/108) | 3.09 | 0.0 | 2.1e-05 |
GO:0009987 | cellular process | 75.93% (82/108) | 0.54 | 0.0 | 2.2e-05 |
GO:0003674 | molecular_function | 82.41% (89/108) | 0.46 | 0.0 | 2.2e-05 |
GO:0016043 | cellular component organization | 36.11% (39/108) | 1.14 | 1e-06 | 3.1e-05 |
GO:0006892 | post-Golgi vesicle-mediated transport | 6.48% (7/108) | 3.88 | 1e-06 | 3.3e-05 |
GO:0015031 | protein transport | 13.89% (15/108) | 2.25 | 1e-06 | 3.5e-05 |
GO:0019222 | regulation of metabolic process | 39.81% (43/108) | 1.05 | 1e-06 | 3.5e-05 |
GO:0051129 | negative regulation of cellular component organization | 9.26% (10/108) | 2.98 | 1e-06 | 3.6e-05 |
GO:0023057 | negative regulation of signaling | 14.81% (16/108) | 2.14 | 1e-06 | 3.8e-05 |
GO:0010648 | negative regulation of cell communication | 14.81% (16/108) | 2.14 | 1e-06 | 3.8e-05 |
GO:0098588 | bounding membrane of organelle | 23.15% (25/108) | 1.56 | 1e-06 | 3.8e-05 |
GO:1901096 | regulation of autophagosome maturation | 2.78% (3/108) | 7.08 | 1e-06 | 5.9e-05 |
GO:0030234 | enzyme regulator activity | 12.04% (13/108) | 2.4 | 1e-06 | 5.9e-05 |
GO:0048583 | regulation of response to stimulus | 31.48% (34/108) | 1.22 | 1e-06 | 6.3e-05 |
GO:0060255 | regulation of macromolecule metabolic process | 34.26% (37/108) | 1.12 | 2e-06 | 9.2e-05 |
GO:0051246 | regulation of protein metabolic process | 18.52% (20/108) | 1.74 | 2e-06 | 9.2e-05 |
GO:0043170 | macromolecule metabolic process | 42.59% (46/108) | 0.93 | 2e-06 | 0.000105 |
GO:0009968 | negative regulation of signal transduction | 13.89% (15/108) | 2.09 | 2e-06 | 0.00011 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 6.48% (7/108) | 3.55 | 2e-06 | 0.000114 |
GO:0043244 | regulation of protein-containing complex disassembly | 5.56% (6/108) | 3.98 | 2e-06 | 0.000116 |
GO:0042176 | regulation of protein catabolic process | 8.33% (9/108) | 2.94 | 3e-06 | 0.000129 |
GO:0019538 | protein metabolic process | 30.56% (33/108) | 1.18 | 3e-06 | 0.00014 |
GO:0006886 | intracellular protein transport | 11.11% (12/108) | 2.39 | 3e-06 | 0.000141 |
GO:0065008 | regulation of biological quality | 27.78% (30/108) | 1.27 | 3e-06 | 0.000141 |
GO:0098791 | Golgi apparatus subcompartment | 11.11% (12/108) | 2.38 | 3e-06 | 0.000147 |
GO:0080090 | regulation of primary metabolic process | 33.33% (36/108) | 1.1 | 3e-06 | 0.000148 |
GO:0048869 | cellular developmental process | 21.3% (23/108) | 1.51 | 4e-06 | 0.000167 |
GO:0005802 | trans-Golgi network | 10.19% (11/108) | 2.51 | 4e-06 | 0.000167 |
GO:0030162 | regulation of proteolysis | 9.26% (10/108) | 2.66 | 5e-06 | 0.000186 |
GO:0044260 | cellular macromolecule metabolic process | 23.15% (25/108) | 1.4 | 5e-06 | 0.000212 |
GO:0032502 | developmental process | 47.22% (51/108) | 0.81 | 6e-06 | 0.000212 |
GO:0031324 | negative regulation of cellular metabolic process | 18.52% (20/108) | 1.64 | 5e-06 | 0.000214 |
GO:0048584 | positive regulation of response to stimulus | 19.44% (21/108) | 1.58 | 5e-06 | 0.000216 |
GO:0043228 | non-membrane-bounded organelle | 23.15% (25/108) | 1.39 | 6e-06 | 0.000232 |
GO:0043232 | intracellular non-membrane-bounded organelle | 23.15% (25/108) | 1.39 | 6e-06 | 0.000232 |
GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 6.48% (7/108) | 3.34 | 6e-06 | 0.000235 |
GO:0051130 | positive regulation of cellular component organization | 10.19% (11/108) | 2.44 | 6e-06 | 0.000237 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 18.52% (20/108) | 1.61 | 7e-06 | 0.000247 |
GO:0010564 | regulation of cell cycle process | 10.19% (11/108) | 2.42 | 7e-06 | 0.00026 |
GO:0036211 | protein modification process | 25.0% (27/108) | 1.3 | 8e-06 | 0.000281 |
GO:0016197 | endosomal transport | 6.48% (7/108) | 3.29 | 8e-06 | 0.000282 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 4.63% (5/108) | 4.19 | 9e-06 | 0.000292 |
GO:0098772 | molecular function regulator activity | 12.04% (13/108) | 2.13 | 9e-06 | 0.000298 |
GO:0042147 | retrograde transport, endosome to Golgi | 4.63% (5/108) | 4.18 | 9e-06 | 0.000299 |
GO:0031981 | nuclear lumen | 5.56% (6/108) | 3.63 | 1e-05 | 0.00033 |
GO:0048585 | negative regulation of response to stimulus | 17.59% (19/108) | 1.63 | 1e-05 | 0.00034 |
GO:0061136 | regulation of proteasomal protein catabolic process | 6.48% (7/108) | 3.22 | 1.1e-05 | 0.000349 |
GO:0099023 | vesicle tethering complex | 4.63% (5/108) | 4.12 | 1.1e-05 | 0.00035 |
GO:0051726 | regulation of cell cycle | 12.04% (13/108) | 2.1 | 1.1e-05 | 0.000356 |
GO:0045807 | positive regulation of endocytosis | 4.63% (5/108) | 4.09 | 1.2e-05 | 0.000372 |
GO:0010008 | endosome membrane | 7.41% (8/108) | 2.91 | 1.2e-05 | 0.000373 |
GO:0043227 | membrane-bounded organelle | 55.56% (60/108) | 0.65 | 1.3e-05 | 0.000401 |
GO:0060090 | molecular adaptor activity | 6.48% (7/108) | 3.18 | 1.4e-05 | 0.000404 |
GO:0051239 | regulation of multicellular organismal process | 21.3% (23/108) | 1.41 | 1.3e-05 | 0.000405 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.7% (4/108) | 4.74 | 1.6e-05 | 0.000464 |
GO:0051171 | regulation of nitrogen compound metabolic process | 30.56% (33/108) | 1.07 | 1.7e-05 | 0.000498 |
GO:0023056 | positive regulation of signaling | 12.04% (13/108) | 2.03 | 1.9e-05 | 0.000546 |
GO:0061061 | muscle structure development | 3.7% (4/108) | 4.67 | 1.9e-05 | 0.000554 |
GO:0016604 | nuclear body | 9.26% (10/108) | 2.42 | 1.9e-05 | 0.000559 |
GO:0010647 | positive regulation of cell communication | 12.04% (13/108) | 2.01 | 2.1e-05 | 0.000601 |
GO:0071705 | nitrogen compound transport | 15.74% (17/108) | 1.67 | 2.3e-05 | 0.000639 |
GO:0009894 | regulation of catabolic process | 11.11% (12/108) | 2.1 | 2.5e-05 | 0.000685 |
GO:1902531 | regulation of intracellular signal transduction | 11.11% (12/108) | 2.1 | 2.5e-05 | 0.000685 |
GO:0043242 | negative regulation of protein-containing complex disassembly | 3.7% (4/108) | 4.57 | 2.5e-05 | 0.000685 |
GO:0140535 | intracellular protein-containing complex | 11.11% (12/108) | 2.1 | 2.5e-05 | 0.000691 |
GO:1903050 | regulation of proteolysis involved in protein catabolic process | 6.48% (7/108) | 3.03 | 2.6e-05 | 0.000693 |
GO:0030182 | neuron differentiation | 4.63% (5/108) | 3.86 | 2.6e-05 | 0.000698 |
GO:0001881 | receptor recycling | 2.78% (3/108) | 5.69 | 2.6e-05 | 0.000701 |
GO:0031984 | organelle subcompartment | 12.04% (13/108) | 1.97 | 2.7e-05 | 0.000707 |
GO:0031323 | regulation of cellular metabolic process | 32.41% (35/108) | 0.99 | 2.8e-05 | 0.000717 |
GO:0030659 | cytoplasmic vesicle membrane | 9.26% (10/108) | 2.35 | 2.8e-05 | 0.000721 |
GO:0051248 | negative regulation of protein metabolic process | 10.19% (11/108) | 2.2 | 2.9e-05 | 0.000727 |
GO:1901799 | negative regulation of proteasomal protein catabolic process | 3.7% (4/108) | 4.52 | 2.9e-05 | 0.000731 |
GO:0010605 | negative regulation of macromolecule metabolic process | 19.44% (21/108) | 1.42 | 3e-05 | 0.000747 |
GO:0051050 | positive regulation of transport | 8.33% (9/108) | 2.51 | 3.2e-05 | 0.000781 |
GO:0030100 | regulation of endocytosis | 5.56% (6/108) | 3.32 | 3.3e-05 | 0.000796 |
GO:0120025 | plasma membrane bounded cell projection | 12.04% (13/108) | 1.94 | 3.5e-05 | 0.000851 |
GO:0051493 | regulation of cytoskeleton organization | 6.48% (7/108) | 2.95 | 3.6e-05 | 0.000874 |
GO:0000139 | Golgi membrane | 8.33% (9/108) | 2.47 | 3.9e-05 | 0.000915 |
GO:0005856 | cytoskeleton | 8.33% (9/108) | 2.47 | 3.9e-05 | 0.000915 |
GO:0006896 | Golgi to vacuole transport | 3.7% (4/108) | 4.41 | 3.9e-05 | 0.000917 |
GO:1904427 | positive regulation of calcium ion transmembrane transport | 2.78% (3/108) | 5.5 | 4e-05 | 0.000925 |
GO:0032153 | cell division site | 3.7% (4/108) | 4.39 | 4.1e-05 | 0.000927 |
GO:0009967 | positive regulation of signal transduction | 11.11% (12/108) | 2.02 | 4.1e-05 | 0.000929 |
GO:0012506 | vesicle membrane | 9.26% (10/108) | 2.29 | 4.1e-05 | 0.000934 |
GO:0006470 | protein dephosphorylation | 5.56% (6/108) | 3.26 | 4.1e-05 | 0.000936 |
GO:0065009 | regulation of molecular function | 15.74% (17/108) | 1.6 | 4.1e-05 | 0.00094 |
GO:0009892 | negative regulation of metabolic process | 20.37% (22/108) | 1.34 | 4.4e-05 | 0.000971 |
GO:0080135 | regulation of cellular response to stress | 9.26% (10/108) | 2.27 | 4.6e-05 | 0.000987 |
GO:1901097 | negative regulation of autophagosome maturation | 1.85% (2/108) | 7.5 | 4.5e-05 | 0.000987 |
GO:0035042 | obsolete fertilization, exchange of chromosomal proteins | 1.85% (2/108) | 7.5 | 4.5e-05 | 0.000987 |
GO:0030141 | secretory granule | 4.63% (5/108) | 3.67 | 4.9e-05 | 0.001047 |
GO:0030154 | cell differentiation | 14.81% (16/108) | 1.64 | 5.1e-05 | 0.00108 |
GO:0098796 | membrane protein complex | 9.26% (10/108) | 2.25 | 5.3e-05 | 0.001114 |
GO:0043412 | macromolecule modification | 25.93% (28/108) | 1.11 | 5.4e-05 | 0.00113 |
GO:0048471 | perinuclear region of cytoplasm | 7.41% (8/108) | 2.6 | 5.5e-05 | 0.001158 |
GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 3.7% (4/108) | 4.23 | 6.4e-05 | 0.001325 |
GO:0010468 | regulation of gene expression | 26.85% (29/108) | 1.07 | 6.8e-05 | 0.0014 |
GO:0071702 | organic substance transport | 16.67% (18/108) | 1.48 | 7e-05 | 0.001423 |
GO:0010941 | regulation of cell death | 12.04% (13/108) | 1.84 | 7.1e-05 | 0.001423 |
GO:0031090 | organelle membrane | 26.85% (29/108) | 1.06 | 7.1e-05 | 0.001431 |
GO:0016241 | regulation of macroautophagy | 3.7% (4/108) | 4.2 | 7.1e-05 | 0.001434 |
GO:0031329 | regulation of cellular catabolic process | 9.26% (10/108) | 2.19 | 7.4e-05 | 0.001468 |
GO:0051668 | localization within membrane | 7.41% (8/108) | 2.53 | 7.8e-05 | 0.001541 |
GO:0048863 | stem cell differentiation | 2.78% (3/108) | 5.18 | 7.9e-05 | 0.001548 |
GO:0009893 | positive regulation of metabolic process | 22.22% (24/108) | 1.2 | 8e-05 | 0.001562 |
GO:0042995 | cell projection | 12.04% (13/108) | 1.82 | 8.2e-05 | 0.001588 |
GO:0051646 | mitochondrion localization | 3.7% (4/108) | 4.12 | 8.6e-05 | 0.001646 |
GO:0010638 | positive regulation of organelle organization | 6.48% (7/108) | 2.74 | 9.3e-05 | 0.001783 |
GO:0030131 | clathrin adaptor complex | 2.78% (3/108) | 5.08 | 9.6e-05 | 0.00181 |
GO:0040028 | regulation of vulval development | 2.78% (3/108) | 5.08 | 9.6e-05 | 0.00181 |
GO:0010639 | negative regulation of organelle organization | 5.56% (6/108) | 3.03 | 9.8e-05 | 0.00181 |
GO:1905368 | peptidase complex | 3.7% (4/108) | 4.07 | 9.8e-05 | 0.001818 |
GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 3.7% (4/108) | 4.07 | 9.8e-05 | 0.001818 |
GO:0050793 | regulation of developmental process | 24.07% (26/108) | 1.12 | 9.8e-05 | 0.001836 |
GO:0051928 | positive regulation of calcium ion transport | 2.78% (3/108) | 5.04 | 0.000105 | 0.001924 |
GO:0031400 | negative regulation of protein modification process | 6.48% (7/108) | 2.7 | 0.000108 | 0.001958 |
GO:0098876 | vesicle-mediated transport to the plasma membrane | 4.63% (5/108) | 3.42 | 0.000111 | 0.001998 |
GO:0045202 | synapse | 7.41% (8/108) | 2.46 | 0.000114 | 0.002036 |
GO:0016311 | dephosphorylation | 6.48% (7/108) | 2.69 | 0.000115 | 0.002047 |
GO:0051495 | positive regulation of cytoskeleton organization | 3.7% (4/108) | 4.01 | 0.000117 | 0.002077 |
GO:0006508 | proteolysis | 12.04% (13/108) | 1.76 | 0.00012 | 0.002112 |
GO:0006897 | endocytosis | 5.56% (6/108) | 2.97 | 0.000125 | 0.002194 |
GO:0030695 | GTPase regulator activity | 4.63% (5/108) | 3.37 | 0.00013 | 0.002255 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 4.63% (5/108) | 3.37 | 0.00013 | 0.002255 |
GO:0043005 | neuron projection | 7.41% (8/108) | 2.42 | 0.000132 | 0.002276 |
GO:0030119 | AP-type membrane coat adaptor complex | 2.78% (3/108) | 4.91 | 0.000137 | 0.002327 |
GO:0005905 | clathrin-coated pit | 2.78% (3/108) | 4.91 | 0.000137 | 0.002327 |
GO:0044877 | protein-containing complex binding | 10.19% (11/108) | 1.94 | 0.000144 | 0.002432 |
GO:0048259 | regulation of receptor-mediated endocytosis | 3.7% (4/108) | 3.91 | 0.000151 | 0.002513 |
GO:0046578 | regulation of Ras protein signal transduction | 3.7% (4/108) | 3.91 | 0.000151 | 0.002513 |
GO:0007585 | respiratory gaseous exchange by respiratory system | 1.85% (2/108) | 6.69 | 0.000157 | 0.002597 |
GO:0035010 | encapsulation of foreign target | 1.85% (2/108) | 6.69 | 0.000157 | 0.002597 |
GO:0030030 | cell projection organization | 6.48% (7/108) | 2.59 | 0.000173 | 0.002834 |
GO:0046872 | metal ion binding | 23.15% (25/108) | 1.1 | 0.000178 | 0.002885 |
GO:0007034 | vacuolar transport | 5.56% (6/108) | 2.88 | 0.00018 | 0.002898 |
GO:0032956 | regulation of actin cytoskeleton organization | 4.63% (5/108) | 3.27 | 0.000178 | 0.002899 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.78% (3/108) | 4.76 | 0.000188 | 0.003002 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 2.78% (3/108) | 4.76 | 0.000188 | 0.003002 |
GO:0002090 | regulation of receptor internalization | 2.78% (3/108) | 4.73 | 0.000203 | 0.003214 |
GO:0020018 | ciliary pocket membrane | 1.85% (2/108) | 6.5 | 0.000209 | 0.003271 |
GO:0036121 | double-stranded DNA helicase activity | 1.85% (2/108) | 6.5 | 0.000209 | 0.003271 |
GO:0060218 | hematopoietic stem cell differentiation | 1.85% (2/108) | 6.5 | 0.000209 | 0.003271 |
GO:1901564 | organonitrogen compound metabolic process | 37.04% (40/108) | 0.77 | 0.000215 | 0.003344 |
GO:0043231 | intracellular membrane-bounded organelle | 51.85% (56/108) | 0.57 | 0.000221 | 0.003392 |
GO:0016020 | membrane | 44.44% (48/108) | 0.66 | 0.000223 | 0.003397 |
GO:0007041 | lysosomal transport | 3.7% (4/108) | 3.77 | 0.00022 | 0.003405 |
GO:1902533 | positive regulation of intracellular signal transduction | 6.48% (7/108) | 2.53 | 0.000223 | 0.003409 |
GO:0045595 | regulation of cell differentiation | 9.26% (10/108) | 1.98 | 0.000231 | 0.003489 |
GO:0140096 | catalytic activity, acting on a protein | 22.22% (24/108) | 1.1 | 0.000234 | 0.003517 |
GO:0120036 | plasma membrane bounded cell projection organization | 5.56% (6/108) | 2.8 | 0.000238 | 0.003568 |
GO:0045862 | positive regulation of proteolysis | 5.56% (6/108) | 2.79 | 0.000242 | 0.003611 |
GO:0050790 | regulation of catalytic activity | 11.11% (12/108) | 1.75 | 0.000245 | 0.003629 |
GO:0120035 | regulation of plasma membrane bounded cell projection organization | 5.56% (6/108) | 2.79 | 0.000247 | 0.003636 |
GO:0005778 | peroxisomal membrane | 3.7% (4/108) | 3.72 | 0.000254 | 0.003652 |
GO:0031903 | microbody membrane | 3.7% (4/108) | 3.72 | 0.000254 | 0.003652 |
GO:0006672 | ceramide metabolic process | 2.78% (3/108) | 4.63 | 0.00025 | 0.003669 |
GO:0043169 | cation binding | 23.15% (25/108) | 1.07 | 0.000254 | 0.003688 |
GO:0022402 | cell cycle process | 12.04% (13/108) | 1.65 | 0.000253 | 0.003689 |
GO:0032970 | regulation of actin filament-based process | 4.63% (5/108) | 3.16 | 0.00026 | 0.003717 |
GO:1901387 | positive regulation of voltage-gated calcium channel activity | 1.85% (2/108) | 6.33 | 0.000269 | 0.003754 |
GO:0015924 | mannosyl-oligosaccharide mannosidase activity | 1.85% (2/108) | 6.33 | 0.000269 | 0.003754 |
GO:0048286 | lung alveolus development | 1.85% (2/108) | 6.33 | 0.000269 | 0.003754 |
GO:0040027 | negative regulation of vulval development | 1.85% (2/108) | 6.33 | 0.000269 | 0.003754 |
GO:0061064 | negative regulation of nematode larval development | 1.85% (2/108) | 6.33 | 0.000269 | 0.003754 |
GO:0042127 | regulation of cell population proliferation | 9.26% (10/108) | 1.95 | 0.000279 | 0.003851 |
GO:2000026 | regulation of multicellular organismal development | 14.81% (16/108) | 1.43 | 0.000278 | 0.003858 |
GO:0043112 | receptor metabolic process | 2.78% (3/108) | 4.56 | 0.000286 | 0.00393 |
GO:0031344 | regulation of cell projection organization | 5.56% (6/108) | 2.74 | 0.000296 | 0.004061 |
GO:0044238 | primary metabolic process | 48.15% (52/108) | 0.6 | 0.000303 | 0.00413 |
GO:0090066 | regulation of anatomical structure size | 5.56% (6/108) | 2.72 | 0.000316 | 0.004273 |
GO:0005815 | microtubule organizing center | 6.48% (7/108) | 2.45 | 0.000316 | 0.004286 |
GO:0060170 | ciliary membrane | 1.85% (2/108) | 6.18 | 0.000335 | 0.00451 |
GO:0045786 | negative regulation of cell cycle | 5.56% (6/108) | 2.71 | 0.000337 | 0.004515 |
GO:0021953 | central nervous system neuron differentiation | 2.78% (3/108) | 4.47 | 0.000345 | 0.004589 |
GO:0000502 | proteasome complex | 2.78% (3/108) | 4.44 | 0.000366 | 0.00485 |
GO:0006807 | nitrogen compound metabolic process | 43.52% (47/108) | 0.64 | 0.000371 | 0.004903 |
GO:0007281 | germ cell development | 4.63% (5/108) | 3.04 | 0.000376 | 0.004938 |
GO:0044396 | actin cortical patch organization | 1.85% (2/108) | 6.04 | 0.000409 | 0.005306 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 1.85% (2/108) | 6.04 | 0.000409 | 0.005306 |
GO:0004559 | alpha-mannosidase activity | 1.85% (2/108) | 6.04 | 0.000409 | 0.005306 |
GO:0060548 | negative regulation of cell death | 7.41% (8/108) | 2.16 | 0.00045 | 0.005806 |
GO:0030120 | vesicle coat | 2.78% (3/108) | 4.33 | 0.000459 | 0.0059 |
GO:1905369 | endopeptidase complex | 2.78% (3/108) | 4.3 | 0.000485 | 0.006201 |
GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain | 1.85% (2/108) | 5.91 | 0.00049 | 0.006217 |
GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process | 1.85% (2/108) | 5.91 | 0.00049 | 0.006217 |
GO:0030674 | protein-macromolecule adaptor activity | 4.63% (5/108) | 2.95 | 0.000498 | 0.006283 |
GO:0042177 | negative regulation of protein catabolic process | 3.7% (4/108) | 3.46 | 0.000507 | 0.00638 |
GO:0018193 | peptidyl-amino acid modification | 9.26% (10/108) | 1.83 | 0.000524 | 0.006565 |
GO:0006357 | regulation of transcription by RNA polymerase II | 11.11% (12/108) | 1.62 | 0.000529 | 0.00659 |
GO:0043167 | ion binding | 31.48% (34/108) | 0.79 | 0.000565 | 0.007016 |
GO:0051983 | regulation of chromosome segregation | 3.7% (4/108) | 3.41 | 0.000568 | 0.007017 |
GO:0090160 | Golgi to lysosome transport | 1.85% (2/108) | 5.8 | 0.000578 | 0.007117 |
GO:0031023 | microtubule organizing center organization | 2.78% (3/108) | 4.2 | 0.000596 | 0.007301 |
GO:0051962 | positive regulation of nervous system development | 3.7% (4/108) | 3.38 | 0.000616 | 0.00752 |
GO:0030148 | sphingolipid biosynthetic process | 2.78% (3/108) | 4.18 | 0.000626 | 0.007574 |
GO:0031330 | negative regulation of cellular catabolic process | 4.63% (5/108) | 2.88 | 0.000624 | 0.00758 |
GO:0060341 | regulation of cellular localization | 7.41% (8/108) | 2.07 | 0.000684 | 0.008246 |
GO:0005776 | autophagosome | 2.78% (3/108) | 4.13 | 0.000689 | 0.008268 |
GO:0001933 | negative regulation of protein phosphorylation | 3.7% (4/108) | 3.32 | 0.000722 | 0.008627 |
GO:0051247 | positive regulation of protein metabolic process | 9.26% (10/108) | 1.77 | 0.000726 | 0.008642 |
GO:0007033 | vacuole organization | 4.63% (5/108) | 2.83 | 0.000733 | 0.00869 |
GO:0070647 | protein modification by small protein conjugation or removal | 10.19% (11/108) | 1.66 | 0.000749 | 0.00884 |
GO:0051446 | positive regulation of meiotic cell cycle | 2.78% (3/108) | 4.08 | 0.000756 | 0.008889 |
GO:0086036 | regulation of cardiac muscle cell membrane potential | 1.85% (2/108) | 5.59 | 0.000776 | 0.009011 |
GO:0007525 | somatic muscle development | 1.85% (2/108) | 5.59 | 0.000776 | 0.009011 |
GO:0061628 | H3K27me3 modified histone binding | 1.85% (2/108) | 5.59 | 0.000776 | 0.009011 |
GO:0005849 | mRNA cleavage factor complex | 2.78% (3/108) | 4.06 | 0.000791 | 0.009152 |
GO:0016570 | histone modification | 6.48% (7/108) | 2.22 | 0.000809 | 0.009324 |
GO:0098793 | presynapse | 3.7% (4/108) | 3.27 | 0.000819 | 0.009403 |
GO:0009896 | positive regulation of catabolic process | 6.48% (7/108) | 2.21 | 0.000835 | 0.009551 |
GO:0140513 | nuclear protein-containing complex | 11.11% (12/108) | 1.55 | 0.000846 | 0.009639 |
GO:1990234 | transferase complex | 9.26% (10/108) | 1.74 | 0.000855 | 0.009696 |
GO:0031491 | nucleosome binding | 2.78% (3/108) | 4.02 | 0.000864 | 0.009764 |
GO:1905189 | regulation of metaphase/anaphase transition of meiosis II | 1.85% (2/108) | 5.5 | 0.000885 | 0.009884 |
GO:0034498 | early endosome to Golgi transport | 1.85% (2/108) | 5.5 | 0.000885 | 0.009884 |
GO:0060303 | obsolete regulation of nucleosome density | 1.85% (2/108) | 5.5 | 0.000885 | 0.009884 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 2.78% (3/108) | 4.0 | 0.000902 | 0.010037 |
GO:0008287 | protein serine/threonine phosphatase complex | 2.78% (3/108) | 3.98 | 0.000941 | 0.010354 |
GO:1903293 | phosphatase complex | 2.78% (3/108) | 3.98 | 0.000941 | 0.010354 |
GO:0072657 | protein localization to membrane | 5.56% (6/108) | 2.42 | 0.000938 | 0.010401 |
GO:0099503 | secretory vesicle | 4.63% (5/108) | 2.74 | 0.000962 | 0.010545 |
GO:0044088 | regulation of vacuole organization | 2.78% (3/108) | 3.96 | 0.000981 | 0.010715 |
GO:0043067 | regulation of programmed cell death | 9.26% (10/108) | 1.71 | 0.000988 | 0.010747 |
GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 1.85% (2/108) | 5.41 | 0.001001 | 0.010768 |
GO:0006491 | N-glycan processing | 1.85% (2/108) | 5.41 | 0.001001 | 0.010768 |
GO:0030125 | clathrin vesicle coat | 1.85% (2/108) | 5.41 | 0.001001 | 0.010768 |
GO:0042981 | regulation of apoptotic process | 7.41% (8/108) | 1.98 | 0.001009 | 0.010771 |
GO:0048513 | animal organ development | 9.26% (10/108) | 1.71 | 0.001008 | 0.010806 |
GO:0005694 | chromosome | 6.48% (7/108) | 2.16 | 0.001039 | 0.011052 |
GO:0061659 | ubiquitin-like protein ligase activity | 5.56% (6/108) | 2.39 | 0.00105 | 0.011133 |
GO:0006974 | cellular response to DNA damage stimulus | 8.33% (9/108) | 1.81 | 0.001103 | 0.011644 |
GO:0043679 | axon terminus | 1.85% (2/108) | 5.33 | 0.001124 | 0.011787 |
GO:1903358 | regulation of Golgi organization | 1.85% (2/108) | 5.33 | 0.001124 | 0.011787 |
GO:1902905 | positive regulation of supramolecular fiber organization | 2.78% (3/108) | 3.88 | 0.001153 | 0.012044 |
GO:0050890 | cognition | 3.7% (4/108) | 3.13 | 0.001166 | 0.012141 |
GO:0140030 | modification-dependent protein binding | 3.7% (4/108) | 3.12 | 0.001219 | 0.012647 |
GO:1903779 | regulation of cardiac conduction | 1.85% (2/108) | 5.25 | 0.001254 | 0.012736 |
GO:0005705 | polytene chromosome interband | 1.85% (2/108) | 5.25 | 0.001254 | 0.012736 |
GO:0007098 | centrosome cycle | 1.85% (2/108) | 5.25 | 0.001254 | 0.012736 |
GO:0021895 | cerebral cortex neuron differentiation | 1.85% (2/108) | 5.25 | 0.001254 | 0.012736 |
GO:1902532 | negative regulation of intracellular signal transduction | 5.56% (6/108) | 2.34 | 0.001245 | 0.012818 |
GO:0010948 | negative regulation of cell cycle process | 4.63% (5/108) | 2.66 | 0.001241 | 0.012822 |
GO:0042326 | negative regulation of phosphorylation | 3.7% (4/108) | 3.1 | 0.001274 | 0.012891 |
GO:0090304 | nucleic acid metabolic process | 17.59% (19/108) | 1.09 | 0.001282 | 0.012925 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 11.11% (12/108) | 1.47 | 0.001353 | 0.013553 |
GO:1901987 | regulation of cell cycle phase transition | 5.56% (6/108) | 2.32 | 0.001352 | 0.013583 |
GO:0051093 | negative regulation of developmental process | 9.26% (10/108) | 1.65 | 0.001367 | 0.013637 |
GO:0030117 | membrane coat | 2.78% (3/108) | 3.78 | 0.001393 | 0.013708 |
GO:1901995 | positive regulation of meiotic cell cycle phase transition | 1.85% (2/108) | 5.18 | 0.001391 | 0.013741 |
GO:1902104 | positive regulation of metaphase/anaphase transition of meiotic cell cycle | 1.85% (2/108) | 5.18 | 0.001391 | 0.013741 |
GO:1905134 | positive regulation of meiotic chromosome separation | 1.85% (2/108) | 5.18 | 0.001391 | 0.013741 |
GO:0019898 | extrinsic component of membrane | 4.63% (5/108) | 2.6 | 0.001464 | 0.014314 |
GO:0008047 | enzyme activator activity | 4.63% (5/108) | 2.6 | 0.001464 | 0.014314 |
GO:0002092 | positive regulation of receptor internalization | 1.85% (2/108) | 5.11 | 0.001535 | 0.014661 |
GO:0030122 | AP-2 adaptor complex | 1.85% (2/108) | 5.11 | 0.001535 | 0.014661 |
GO:0047497 | mitochondrion transport along microtubule | 1.85% (2/108) | 5.11 | 0.001535 | 0.014661 |
GO:0072659 | protein localization to plasma membrane | 3.7% (4/108) | 3.02 | 0.001541 | 0.014675 |
GO:0032535 | regulation of cellular component size | 4.63% (5/108) | 2.59 | 0.001508 | 0.014691 |
GO:1901879 | regulation of protein depolymerization | 2.78% (3/108) | 3.73 | 0.00155 | 0.014711 |
GO:0048468 | cell development | 7.41% (8/108) | 1.89 | 0.001518 | 0.014746 |
GO:0048856 | anatomical structure development | 32.41% (35/108) | 0.7 | 0.001531 | 0.014775 |
GO:0010604 | positive regulation of macromolecule metabolic process | 17.59% (19/108) | 1.07 | 0.001528 | 0.014789 |
GO:0040008 | regulation of growth | 12.04% (13/108) | 1.36 | 0.001646 | 0.015574 |
GO:0006796 | phosphate-containing compound metabolic process | 17.59% (19/108) | 1.06 | 0.001662 | 0.015674 |
GO:0044322 | endoplasmic reticulum quality control compartment | 1.85% (2/108) | 5.04 | 0.001685 | 0.015787 |
GO:0006895 | Golgi to endosome transport | 1.85% (2/108) | 5.04 | 0.001685 | 0.015787 |
GO:1905897 | regulation of response to endoplasmic reticulum stress | 2.78% (3/108) | 3.68 | 0.001719 | 0.015894 |
GO:0032456 | endocytic recycling | 2.78% (3/108) | 3.68 | 0.001719 | 0.015894 |
GO:0034762 | regulation of transmembrane transport | 5.56% (6/108) | 2.25 | 0.001715 | 0.015963 |
GO:0019904 | protein domain specific binding | 6.48% (7/108) | 2.03 | 0.001713 | 0.015993 |
GO:0051336 | regulation of hydrolase activity | 5.56% (6/108) | 2.25 | 0.001753 | 0.016163 |
GO:1903169 | regulation of calcium ion transmembrane transport | 2.78% (3/108) | 3.64 | 0.001837 | 0.016827 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 2.78% (3/108) | 3.64 | 0.001837 | 0.016827 |
GO:0010959 | regulation of metal ion transport | 4.63% (5/108) | 2.52 | 0.001891 | 0.017218 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 2.78% (3/108) | 3.63 | 0.001898 | 0.017224 |
GO:0061024 | membrane organization | 6.48% (7/108) | 2.01 | 0.001891 | 0.017271 |
GO:0051252 | regulation of RNA metabolic process | 19.44% (21/108) | 0.97 | 0.001952 | 0.017662 |
GO:0045806 | negative regulation of endocytosis | 1.85% (2/108) | 4.91 | 0.002006 | 0.017872 |
GO:0007517 | muscle organ development | 1.85% (2/108) | 4.91 | 0.002006 | 0.017872 |
GO:0030118 | clathrin coat | 1.85% (2/108) | 4.91 | 0.002006 | 0.017872 |
GO:0044057 | regulation of system process | 3.7% (4/108) | 2.92 | 0.001993 | 0.017917 |
GO:0051345 | positive regulation of hydrolase activity | 3.7% (4/108) | 2.92 | 0.001993 | 0.017917 |
GO:0006793 | phosphorus metabolic process | 17.59% (19/108) | 1.04 | 0.002023 | 0.017966 |
GO:0044093 | positive regulation of molecular function | 7.41% (8/108) | 1.82 | 0.002055 | 0.018191 |
GO:0008285 | negative regulation of cell population proliferation | 4.63% (5/108) | 2.49 | 0.00208 | 0.01836 |
GO:0010556 | regulation of macromolecule biosynthetic process | 20.37% (22/108) | 0.93 | 0.002124 | 0.018692 |
GO:1902102 | regulation of metaphase/anaphase transition of meiotic cell cycle | 1.85% (2/108) | 4.86 | 0.002177 | 0.018758 |
GO:1905132 | regulation of meiotic chromosome separation | 1.85% (2/108) | 4.86 | 0.002177 | 0.018758 |
GO:0005935 | cellular bud neck | 1.85% (2/108) | 4.86 | 0.002177 | 0.018758 |
GO:0044306 | neuron projection terminus | 1.85% (2/108) | 4.86 | 0.002177 | 0.018758 |
GO:2001259 | positive regulation of cation channel activity | 1.85% (2/108) | 4.86 | 0.002177 | 0.018758 |
GO:0034643 | establishment of mitochondrion localization, microtubule-mediated | 1.85% (2/108) | 4.86 | 0.002177 | 0.018758 |
GO:0009895 | negative regulation of catabolic process | 4.63% (5/108) | 2.47 | 0.002194 | 0.018848 |
GO:0071704 | organic substance metabolic process | 50.93% (55/108) | 0.46 | 0.002162 | 0.018968 |
GO:0009886 | post-embryonic animal morphogenesis | 2.78% (3/108) | 3.55 | 0.002222 | 0.019035 |
GO:0008152 | metabolic process | 53.7% (58/108) | 0.43 | 0.002246 | 0.019182 |
GO:0030111 | regulation of Wnt signaling pathway | 3.7% (4/108) | 2.86 | 0.002312 | 0.01969 |
GO:0016242 | negative regulation of macroautophagy | 1.85% (2/108) | 4.8 | 0.002354 | 0.0197 |
GO:0000145 | exocyst | 1.85% (2/108) | 4.8 | 0.002354 | 0.0197 |
GO:0046513 | ceramide biosynthetic process | 1.85% (2/108) | 4.8 | 0.002354 | 0.0197 |
GO:0051654 | establishment of mitochondrion localization | 1.85% (2/108) | 4.8 | 0.002354 | 0.0197 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1.85% (2/108) | 4.8 | 0.002354 | 0.0197 |
GO:0003682 | chromatin binding | 6.48% (7/108) | 1.95 | 0.002331 | 0.019789 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 20.37% (22/108) | 0.92 | 0.002401 | 0.020038 |
GO:1902903 | regulation of supramolecular fiber organization | 3.7% (4/108) | 2.84 | 0.00244 | 0.020133 |
GO:0045930 | negative regulation of mitotic cell cycle | 3.7% (4/108) | 2.84 | 0.00244 | 0.020133 |
GO:0043967 | histone H4 acetylation | 2.78% (3/108) | 3.5 | 0.002432 | 0.020179 |
GO:0000118 | histone deacetylase complex | 2.78% (3/108) | 3.5 | 0.002432 | 0.020179 |
GO:0006139 | nucleobase-containing compound metabolic process | 19.44% (21/108) | 0.95 | 0.002472 | 0.02034 |
GO:0016055 | Wnt signaling pathway | 1.85% (2/108) | 4.74 | 0.002538 | 0.020701 |
GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling | 1.85% (2/108) | 4.74 | 0.002538 | 0.020701 |
GO:0140312 | cargo adaptor activity | 1.85% (2/108) | 4.74 | 0.002538 | 0.020701 |
GO:0003264 | regulation of cardioblast proliferation | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0071212 | subsynaptic reticulum | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1905062 | positive regulation of cardioblast proliferation | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1905304 | regulation of cardiac myofibril assembly | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1905306 | positive regulation of cardiac myofibril assembly | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0035658 | Mon1-Ccz1 complex | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0035542 | regulation of SNARE complex assembly | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0035543 | positive regulation of SNARE complex assembly | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0099041 | vesicle tethering to Golgi | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0001729 | ceramide kinase activity | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0016561 | protein import into peroxisome matrix, translocation | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0016562 | protein import into peroxisome matrix, receptor recycling | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1900237 | positive regulation of induction of conjugation with cellular fusion | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1901098 | positive regulation of autophagosome maturation | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1901525 | negative regulation of mitophagy | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1903147 | negative regulation of autophagy of mitochondrion | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1903415 | flavonoid transport from endoplasmic reticulum to plant-type vacuole | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1904766 | negative regulation of macroautophagy by TORC1 signaling | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:1904649 | regulation of fat cell apoptotic process | 0.93% (1/108) | 8.5 | 0.002763 | 0.020841 |
GO:0030435 | sporulation resulting in formation of a cellular spore | 2.78% (3/108) | 3.47 | 0.002579 | 0.020858 |
GO:1904064 | positive regulation of cation transmembrane transport | 2.78% (3/108) | 3.47 | 0.002579 | 0.020858 |
GO:2001257 | regulation of cation channel activity | 2.78% (3/108) | 3.47 | 0.002579 | 0.020858 |
GO:0030177 | positive regulation of Wnt signaling pathway | 2.78% (3/108) | 3.43 | 0.002808 | 0.02102 |
GO:0060271 | cilium assembly | 2.78% (3/108) | 3.43 | 0.002808 | 0.02102 |
GO:0051276 | chromosome organization | 5.56% (6/108) | 2.11 | 0.002821 | 0.021061 |
GO:0018394 | peptidyl-lysine acetylation | 3.7% (4/108) | 2.79 | 0.002806 | 0.021112 |
GO:0016573 | histone acetylation | 3.7% (4/108) | 2.81 | 0.002619 | 0.021126 |
GO:0016567 | protein ubiquitination | 8.33% (9/108) | 1.63 | 0.002637 | 0.021213 |
GO:0016607 | nuclear speck | 4.63% (5/108) | 2.38 | 0.002867 | 0.021348 |
GO:0016581 | NuRD complex | 1.85% (2/108) | 4.64 | 0.002925 | 0.021557 |
GO:0042766 | obsolete nucleosome mobilization | 1.85% (2/108) | 4.64 | 0.002925 | 0.021557 |
GO:0090545 | CHD-type complex | 1.85% (2/108) | 4.64 | 0.002925 | 0.021557 |
GO:0016239 | positive regulation of macroautophagy | 1.85% (2/108) | 4.64 | 0.002925 | 0.021557 |
GO:0051240 | positive regulation of multicellular organismal process | 8.33% (9/108) | 1.6 | 0.00295 | 0.021633 |
GO:0016787 | hydrolase activity | 19.44% (21/108) | 0.92 | 0.002945 | 0.02165 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 7.41% (8/108) | 1.73 | 0.00297 | 0.021728 |
GO:0006665 | sphingolipid metabolic process | 2.78% (3/108) | 3.44 | 0.00273 | 0.021844 |
GO:1901993 | regulation of meiotic cell cycle phase transition | 1.85% (2/108) | 4.69 | 0.002728 | 0.021884 |
GO:0004721 | phosphoprotein phosphatase activity | 3.7% (4/108) | 2.76 | 0.003003 | 0.021908 |
GO:0006475 | internal protein amino acid acetylation | 3.7% (4/108) | 2.79 | 0.002759 | 0.021948 |
GO:0018393 | internal peptidyl-lysine acetylation | 3.7% (4/108) | 2.79 | 0.002759 | 0.021948 |
GO:0009653 | anatomical structure morphogenesis | 17.59% (19/108) | 0.98 | 0.003052 | 0.022158 |
GO:0090257 | regulation of muscle system process | 2.78% (3/108) | 3.38 | 0.003051 | 0.022203 |
GO:0005509 | calcium ion binding | 4.63% (5/108) | 2.35 | 0.003084 | 0.022334 |
GO:0007051 | spindle organization | 3.7% (4/108) | 2.73 | 0.003208 | 0.023117 |
GO:0051960 | regulation of nervous system development | 3.7% (4/108) | 2.73 | 0.003208 | 0.023117 |
GO:0006517 | protein deglycosylation | 1.85% (2/108) | 4.55 | 0.003338 | 0.023874 |
GO:0007476 | imaginal disc-derived wing morphogenesis | 1.85% (2/108) | 4.55 | 0.003338 | 0.023874 |
GO:0016584 | obsolete nucleosome positioning | 1.85% (2/108) | 4.55 | 0.003338 | 0.023874 |
GO:0032446 | protein modification by small protein conjugation | 8.33% (9/108) | 1.58 | 0.003352 | 0.023914 |
GO:0010563 | negative regulation of phosphorus metabolic process | 3.7% (4/108) | 2.71 | 0.003368 | 0.023916 |
GO:0045936 | negative regulation of phosphate metabolic process | 3.7% (4/108) | 2.71 | 0.003368 | 0.023916 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 2.78% (3/108) | 3.32 | 0.003482 | 0.024424 |
GO:0032465 | regulation of cytokinesis | 2.78% (3/108) | 3.32 | 0.003482 | 0.024424 |
GO:0003008 | system process | 6.48% (7/108) | 1.85 | 0.003496 | 0.024464 |
GO:0031974 | membrane-enclosed lumen | 7.41% (8/108) | 1.69 | 0.003475 | 0.024497 |
GO:0043233 | organelle lumen | 7.41% (8/108) | 1.69 | 0.003475 | 0.024497 |
GO:0070013 | intracellular organelle lumen | 7.41% (8/108) | 1.69 | 0.003475 | 0.024497 |
GO:0110020 | regulation of actomyosin structure organization | 1.85% (2/108) | 4.5 | 0.003554 | 0.02469 |
GO:1904292 | regulation of ERAD pathway | 1.85% (2/108) | 4.5 | 0.003554 | 0.02469 |
GO:0035114 | imaginal disc-derived appendage morphogenesis | 1.85% (2/108) | 4.5 | 0.003554 | 0.02469 |
GO:0044782 | cilium organization | 2.78% (3/108) | 3.3 | 0.003572 | 0.02476 |
GO:1990778 | protein localization to cell periphery | 3.7% (4/108) | 2.69 | 0.00359 | 0.024766 |
GO:0006473 | protein acetylation | 3.7% (4/108) | 2.69 | 0.00359 | 0.024766 |
GO:2000241 | regulation of reproductive process | 11.11% (12/108) | 1.29 | 0.003623 | 0.024934 |
GO:0098797 | plasma membrane protein complex | 2.78% (3/108) | 3.29 | 0.003664 | 0.025157 |
GO:0043069 | negative regulation of programmed cell death | 5.56% (6/108) | 2.02 | 0.003776 | 0.025742 |
GO:0005769 | early endosome | 3.7% (4/108) | 2.67 | 0.003763 | 0.025776 |
GO:0031399 | regulation of protein modification process | 8.33% (9/108) | 1.55 | 0.003773 | 0.025781 |
GO:0033045 | regulation of sister chromatid segregation | 2.78% (3/108) | 3.25 | 0.003949 | 0.026793 |
GO:1904062 | regulation of cation transmembrane transport | 3.7% (4/108) | 2.65 | 0.003942 | 0.026809 |
GO:0030510 | regulation of BMP signaling pathway | 1.85% (2/108) | 4.41 | 0.004005 | 0.026986 |
GO:0051693 | actin filament capping | 1.85% (2/108) | 4.41 | 0.004005 | 0.026986 |
GO:0035120 | post-embryonic appendage morphogenesis | 1.85% (2/108) | 4.41 | 0.004005 | 0.026986 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 15.74% (17/108) | 1.02 | 0.004067 | 0.027337 |
GO:0018105 | peptidyl-serine phosphorylation | 3.7% (4/108) | 2.63 | 0.004126 | 0.027672 |
GO:0001701 | in utero embryonic development | 2.78% (3/108) | 3.23 | 0.004146 | 0.02774 |
GO:0032501 | multicellular organismal process | 28.7% (31/108) | 0.67 | 0.004216 | 0.028081 |
GO:1905818 | regulation of chromosome separation | 2.78% (3/108) | 3.21 | 0.004246 | 0.02809 |
GO:0045787 | positive regulation of cell cycle | 4.63% (5/108) | 2.25 | 0.00421 | 0.028105 |
GO:2000369 | regulation of clathrin-dependent endocytosis | 1.85% (2/108) | 4.37 | 0.00424 | 0.028114 |
GO:0046580 | negative regulation of Ras protein signal transduction | 1.85% (2/108) | 4.37 | 0.00424 | 0.028114 |
GO:0010506 | regulation of autophagy | 3.7% (4/108) | 2.61 | 0.004316 | 0.028485 |
GO:0010975 | regulation of neuron projection development | 3.7% (4/108) | 2.6 | 0.004381 | 0.028846 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1.85% (2/108) | 4.33 | 0.004482 | 0.029445 |
GO:0009889 | regulation of biosynthetic process | 22.22% (24/108) | 0.8 | 0.004534 | 0.029721 |
GO:0090150 | establishment of protein localization to membrane | 3.7% (4/108) | 2.58 | 0.004645 | 0.030384 |
GO:0031490 | chromatin DNA binding | 2.78% (3/108) | 3.17 | 0.004664 | 0.030434 |
GO:0005703 | polytene chromosome puff | 1.85% (2/108) | 4.29 | 0.004729 | 0.030656 |
GO:0043243 | positive regulation of protein-containing complex disassembly | 1.85% (2/108) | 4.29 | 0.004729 | 0.030656 |
GO:0018209 | peptidyl-serine modification | 3.7% (4/108) | 2.57 | 0.004713 | 0.03069 |
GO:0015629 | actin cytoskeleton | 2.78% (3/108) | 3.14 | 0.004881 | 0.031361 |
GO:0006887 | exocytosis | 2.78% (3/108) | 3.14 | 0.004881 | 0.031361 |
GO:0046467 | membrane lipid biosynthetic process | 2.78% (3/108) | 3.14 | 0.004881 | 0.031361 |
GO:0045861 | negative regulation of proteolysis | 3.7% (4/108) | 2.56 | 0.004851 | 0.031375 |
GO:0050769 | positive regulation of neurogenesis | 2.78% (3/108) | 3.13 | 0.004992 | 0.031724 |
GO:0005938 | cell cortex | 3.7% (4/108) | 2.55 | 0.004991 | 0.031788 |
GO:0070679 | inositol 1,4,5 trisphosphate binding | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0098892 | extrinsic component of postsynaptic specialization membrane | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0098833 | presynaptic endocytic zone | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1905274 | regulation of modification of postsynaptic actin cytoskeleton | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:2001286 | regulation of caveolin-mediated endocytosis | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:2001288 | positive regulation of caveolin-mediated endocytosis | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0010013 | N-1-naphthylphthalamic acid binding | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0004107 | chorismate synthase activity | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0090244 | Wnt signaling pathway involved in somitogenesis | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0090249 | regulation of cell migration involved in somitogenic axis elongation | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0004830 | tryptophan-tRNA ligase activity | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0098992 | neuronal dense core vesicle | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0072756 | cellular response to paraquat | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0060101 | negative regulation of phagocytosis, engulfment | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1905154 | negative regulation of membrane invagination | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0032978 | protein insertion into membrane from inner side | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0032979 | protein insertion into mitochondrial inner membrane from matrix | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0002197 | xanthine dehydrogenase complex | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0034418 | urate biosynthetic process | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0045601 | regulation of endothelial cell differentiation | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0045602 | negative regulation of endothelial cell differentiation | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0048072 | compound eye pigmentation | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0070674 | hypoxanthine dehydrogenase activity | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0070675 | hypoxanthine oxidase activity | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:2001212 | regulation of vasculogenesis | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:2001213 | negative regulation of vasculogenesis | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0010995 | free ubiquitin chain depolymerization | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0006363 | termination of RNA polymerase I transcription | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:1900050 | negative regulation of histone exchange | 0.93% (1/108) | 7.5 | 0.005518 | 0.031797 |
GO:0048488 | synaptic vesicle endocytosis | 1.85% (2/108) | 4.25 | 0.004983 | 0.031804 |
GO:0140238 | presynaptic endocytosis | 1.85% (2/108) | 4.25 | 0.004983 | 0.031804 |
GO:1903573 | negative regulation of response to endoplasmic reticulum stress | 1.85% (2/108) | 4.25 | 0.004983 | 0.031804 |
GO:2001020 | regulation of response to DNA damage stimulus | 3.7% (4/108) | 2.51 | 0.00558 | 0.032027 |
GO:0007005 | mitochondrion organization | 3.7% (4/108) | 2.51 | 0.00558 | 0.032027 |
GO:0051896 | regulation of protein kinase B signaling | 1.85% (2/108) | 4.14 | 0.005781 | 0.032919 |
GO:0015923 | mannosidase activity | 1.85% (2/108) | 4.14 | 0.005781 | 0.032919 |
GO:0062207 | regulation of pattern recognition receptor signaling pathway | 1.85% (2/108) | 4.14 | 0.005781 | 0.032919 |
GO:1901798 | positive regulation of signal transduction by p53 class mediator | 1.85% (2/108) | 4.14 | 0.005781 | 0.032919 |
GO:0098794 | postsynapse | 2.78% (3/108) | 3.11 | 0.005219 | 0.032949 |
GO:0042325 | regulation of phosphorylation | 5.56% (6/108) | 1.92 | 0.005209 | 0.032955 |
GO:0051094 | positive regulation of developmental process | 9.26% (10/108) | 1.38 | 0.005199 | 0.032963 |
GO:0002244 | hematopoietic progenitor cell differentiation | 1.85% (2/108) | 4.21 | 0.005243 | 0.033028 |
GO:0120031 | plasma membrane bounded cell projection assembly | 2.78% (3/108) | 3.05 | 0.005813 | 0.033034 |
GO:0043269 | regulation of ion transport | 5.56% (6/108) | 1.89 | 0.005843 | 0.033142 |
GO:0034765 | regulation of ion transmembrane transport | 4.63% (5/108) | 2.13 | 0.005893 | 0.033292 |
GO:0032880 | regulation of protein localization | 5.56% (6/108) | 1.89 | 0.005891 | 0.033345 |
GO:0032922 | circadian regulation of gene expression | 2.78% (3/108) | 3.04 | 0.005936 | 0.033473 |
GO:0050807 | regulation of synapse organization | 2.78% (3/108) | 3.1 | 0.005335 | 0.033533 |
GO:0051445 | regulation of meiotic cell cycle | 2.78% (3/108) | 3.03 | 0.006061 | 0.033914 |
GO:1905476 | negative regulation of protein localization to membrane | 1.85% (2/108) | 4.11 | 0.006059 | 0.03397 |
GO:0070555 | response to interleukin-1 | 1.85% (2/108) | 4.11 | 0.006059 | 0.03397 |
GO:0046626 | regulation of insulin receptor signaling pathway | 1.85% (2/108) | 4.11 | 0.006059 | 0.03397 |
GO:0044087 | regulation of cellular component biogenesis | 6.48% (7/108) | 1.73 | 0.00543 | 0.033984 |
GO:0030835 | negative regulation of actin filament depolymerization | 1.85% (2/108) | 4.18 | 0.005509 | 0.034039 |
GO:0007009 | plasma membrane organization | 1.85% (2/108) | 4.18 | 0.005509 | 0.034039 |
GO:0061062 | regulation of nematode larval development | 1.85% (2/108) | 4.18 | 0.005509 | 0.034039 |
GO:0045732 | positive regulation of protein catabolic process | 3.7% (4/108) | 2.52 | 0.005429 | 0.034052 |
GO:0051051 | negative regulation of transport | 3.7% (4/108) | 2.51 | 0.005504 | 0.034229 |
GO:0043254 | regulation of protein-containing complex assembly | 3.7% (4/108) | 2.51 | 0.005504 | 0.034229 |
GO:0061630 | ubiquitin protein ligase activity | 4.63% (5/108) | 2.16 | 0.00549 | 0.034285 |
GO:0007017 | microtubule-based process | 6.48% (7/108) | 1.69 | 0.006184 | 0.034536 |
GO:0019899 | enzyme binding | 12.04% (13/108) | 1.13 | 0.006235 | 0.034687 |
GO:0033365 | protein localization to organelle | 6.48% (7/108) | 1.69 | 0.006226 | 0.034703 |
GO:0031326 | regulation of cellular biosynthetic process | 21.3% (23/108) | 0.78 | 0.006263 | 0.034774 |
GO:0006898 | receptor-mediated endocytosis | 2.78% (3/108) | 3.01 | 0.006316 | 0.035002 |
GO:0031137 | regulation of conjugation with cellular fusion | 1.85% (2/108) | 4.07 | 0.006344 | 0.035022 |
GO:0001709 | cell fate determination | 1.85% (2/108) | 4.07 | 0.006344 | 0.035022 |
GO:0051253 | negative regulation of RNA metabolic process | 9.26% (10/108) | 1.34 | 0.006369 | 0.035098 |
GO:0030031 | cell projection assembly | 2.78% (3/108) | 2.98 | 0.006709 | 0.036902 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 1.85% (2/108) | 4.01 | 0.00693 | 0.038042 |
GO:0032386 | regulation of intracellular transport | 3.7% (4/108) | 2.41 | 0.006982 | 0.038186 |
GO:0090068 | positive regulation of cell cycle process | 3.7% (4/108) | 2.41 | 0.006982 | 0.038186 |
GO:0051241 | negative regulation of multicellular organismal process | 7.41% (8/108) | 1.52 | 0.007116 | 0.038842 |
GO:0009910 | negative regulation of flower development | 2.78% (3/108) | 2.93 | 0.007257 | 0.039463 |
GO:0043543 | protein acylation | 3.7% (4/108) | 2.4 | 0.007252 | 0.03951 |
GO:0004722 | protein serine/threonine phosphatase activity | 2.78% (3/108) | 2.92 | 0.007397 | 0.040154 |
GO:0060828 | regulation of canonical Wnt signaling pathway | 2.78% (3/108) | 2.91 | 0.00754 | 0.040473 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2.78% (3/108) | 2.91 | 0.00754 | 0.040473 |
GO:0030837 | negative regulation of actin filament polymerization | 1.85% (2/108) | 3.94 | 0.00754 | 0.040622 |
GO:0005801 | cis-Golgi network | 1.85% (2/108) | 3.94 | 0.00754 | 0.040622 |
GO:0060284 | regulation of cell development | 3.7% (4/108) | 2.38 | 0.007528 | 0.040709 |
GO:0031325 | positive regulation of cellular metabolic process | 15.74% (17/108) | 0.93 | 0.007519 | 0.040736 |
GO:0034767 | positive regulation of ion transmembrane transport | 2.78% (3/108) | 2.9 | 0.007684 | 0.04117 |
GO:0006355 | regulation of DNA-templated transcription | 16.67% (18/108) | 0.89 | 0.007722 | 0.041296 |
GO:0007165 | signal transduction | 18.52% (20/108) | 0.83 | 0.007766 | 0.041456 |
GO:0016791 | phosphatase activity | 4.63% (5/108) | 2.03 | 0.007785 | 0.04148 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 4.63% (5/108) | 2.03 | 0.007857 | 0.04171 |
GO:0010958 | regulation of amino acid import across plasma membrane | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0032891 | negative regulation of organic acid transport | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0051953 | negative regulation of amine transport | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0051956 | negative regulation of amino acid transport | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:1905529 | regulation of uracil import across plasma membrane | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:1905530 | negative regulation of uracil import across plasma membrane | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:1905532 | regulation of leucine import across plasma membrane | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:1905533 | negative regulation of leucine import across plasma membrane | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0016415 | octanoyltransferase activity | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0033819 | lipoyl(octanoyl) transferase activity | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:1904020 | regulation of G protein-coupled receptor internalization | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:1904021 | negative regulation of G protein-coupled receptor internalization | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0032258 | cytoplasm to vacuole transport by the Cvt pathway | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0010835 | regulation of protein ADP-ribosylation | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0036500 | ATF6-mediated unfolded protein response | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0004854 | xanthine dehydrogenase activity | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0004855 | xanthine oxidase activity | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0062210 | shoot regeneration | 0.93% (1/108) | 6.91 | 0.008266 | 0.041749 |
GO:0009992 | cellular water homeostasis | 1.85% (2/108) | 3.91 | 0.007853 | 0.04177 |
GO:1903506 | regulation of nucleic acid-templated transcription | 16.67% (18/108) | 0.88 | 0.007943 | 0.042015 |
GO:0031331 | positive regulation of cellular catabolic process | 4.63% (5/108) | 2.03 | 0.007929 | 0.042018 |
GO:2001141 | regulation of RNA biosynthetic process | 16.67% (18/108) | 0.88 | 0.007988 | 0.042099 |
GO:0019725 | cellular homeostasis | 6.48% (7/108) | 1.62 | 0.007975 | 0.042108 |
GO:0022607 | cellular component assembly | 12.96% (14/108) | 1.03 | 0.008353 | 0.042113 |
GO:0043066 | negative regulation of apoptotic process | 4.63% (5/108) | 2.0 | 0.008449 | 0.042523 |
GO:0032467 | positive regulation of cytokinesis | 1.85% (2/108) | 3.86 | 0.008498 | 0.042697 |
GO:0015630 | microtubule cytoskeleton | 2.78% (3/108) | 2.88 | 0.008126 | 0.042749 |
GO:1901880 | negative regulation of protein depolymerization | 1.85% (2/108) | 3.88 | 0.008173 | 0.042764 |
GO:1901019 | regulation of calcium ion transmembrane transporter activity | 1.85% (2/108) | 3.88 | 0.008173 | 0.042764 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum | 1.85% (2/108) | 3.88 | 0.008173 | 0.042764 |
GO:0044237 | cellular metabolic process | 45.37% (49/108) | 0.42 | 0.00868 | 0.043536 |
GO:0018205 | peptidyl-lysine modification | 4.63% (5/108) | 1.99 | 0.008756 | 0.043842 |
GO:0000151 | ubiquitin ligase complex | 4.63% (5/108) | 1.99 | 0.008834 | 0.044005 |
GO:0006942 | regulation of striated muscle contraction | 1.85% (2/108) | 3.83 | 0.008829 | 0.044055 |
GO:0055117 | regulation of cardiac muscle contraction | 1.85% (2/108) | 3.83 | 0.008829 | 0.044055 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 2.78% (3/108) | 2.83 | 0.008895 | 0.044231 |
GO:0045892 | negative regulation of DNA-templated transcription | 8.33% (9/108) | 1.35 | 0.008963 | 0.044417 |
GO:1903046 | meiotic cell cycle process | 5.56% (6/108) | 1.76 | 0.008955 | 0.044452 |
GO:0000018 | regulation of DNA recombination | 2.78% (3/108) | 2.82 | 0.009054 | 0.04479 |
GO:0055038 | recycling endosome membrane | 1.85% (2/108) | 3.8 | 0.009166 | 0.045269 |
GO:0007611 | learning or memory | 2.78% (3/108) | 2.81 | 0.009214 | 0.045429 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 4.63% (5/108) | 1.97 | 0.009232 | 0.04544 |
GO:0043934 | sporulation | 3.7% (4/108) | 2.29 | 0.009439 | 0.045912 |
GO:0031301 | integral component of organelle membrane | 3.7% (4/108) | 2.29 | 0.009439 | 0.045912 |
GO:1902679 | negative regulation of RNA biosynthetic process | 8.33% (9/108) | 1.34 | 0.009402 | 0.045968 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 8.33% (9/108) | 1.34 | 0.009402 | 0.045968 |
GO:1903828 | negative regulation of protein localization | 2.78% (3/108) | 2.8 | 0.009376 | 0.045994 |
GO:0051924 | regulation of calcium ion transport | 2.78% (3/108) | 2.8 | 0.009376 | 0.045994 |
GO:0006970 | response to osmotic stress | 12.04% (13/108) | 1.06 | 0.009436 | 0.046052 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.85% (2/108) | 3.77 | 0.009508 | 0.046098 |
GO:0007286 | spermatid development | 1.85% (2/108) | 3.77 | 0.009508 | 0.046098 |
GO:0033044 | regulation of chromosome organization | 3.7% (4/108) | 2.28 | 0.009547 | 0.046208 |
GO:0051053 | negative regulation of DNA metabolic process | 2.78% (3/108) | 2.77 | 0.009872 | 0.047703 |
GO:0006281 | DNA repair | 5.56% (6/108) | 1.73 | 0.009889 | 0.047704 |
GO:0034641 | cellular nitrogen compound metabolic process | 22.22% (24/108) | 0.7 | 0.009915 | 0.047751 |
GO:0097159 | organic cyclic compound binding | 35.19% (38/108) | 0.5 | 0.011014 | 0.048464 |
GO:0042538 | hyperosmotic salinity response | 3.7% (4/108) | 2.22 | 0.011032 | 0.048468 |
GO:0016198 | axon choice point recognition | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0016199 | axon midline choice point recognition | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0010732 | regulation of protein glutathionylation | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0010734 | negative regulation of protein glutathionylation | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0044305 | calyx of Held | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0060124 | positive regulation of growth hormone secretion | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0048160 | primary follicle stage | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0016063 | rhodopsin biosynthetic process | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0046154 | rhodopsin metabolic process | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0002091 | negative regulation of receptor internalization | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1904809 | regulation of dense core granule transport | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1990745 | EARP complex | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0002717 | positive regulation of natural killer cell mediated immunity | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0070772 | PAS complex | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0002457 | T cell antigen processing and presentation | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0060763 | mammary duct terminal end bud growth | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:2000864 | regulation of estradiol secretion | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0009847 | spore germination | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0031045 | dense core granule | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0034971 | histone H3-R17 methylation | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0004758 | serine C-palmitoyltransferase activity | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0016454 | C-palmitoyltransferase activity | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0046511 | sphinganine biosynthetic process | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1904502 | regulation of lipophagy | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1904504 | positive regulation of lipophagy | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0016727 | oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0090352 | regulation of nitrate assimilation | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1903314 | regulation of nitrogen cycle metabolic process | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0045501 | regulation of sevenless signaling pathway | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0045874 | positive regulation of sevenless signaling pathway | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0001400 | mating projection base | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0007116 | regulation of cell budding | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1901900 | regulation of protein localization to cell division site | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1901901 | regulation of protein localization to cell division site involved in cytokinesis | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:1903501 | positive regulation of mitotic actomyosin contractile ring assembly | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:2000433 | positive regulation of cytokinesis, actomyosin contractile ring assembly | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0001178 | regulation of transcriptional start site selection at RNA polymerase II promoter | 0.93% (1/108) | 6.5 | 0.011007 | 0.048503 |
GO:0006111 | regulation of gluconeogenesis | 1.85% (2/108) | 3.72 | 0.01021 | 0.049009 |
GO:0098858 | actin-based cell projection | 1.85% (2/108) | 3.72 | 0.01021 | 0.049009 |
GO:0006644 | phospholipid metabolic process | 4.63% (5/108) | 1.9 | 0.011313 | 0.049404 |
GO:0032993 | protein-DNA complex | 2.78% (3/108) | 2.7 | 0.01127 | 0.049436 |
GO:0032272 | negative regulation of protein polymerization | 1.85% (2/108) | 3.64 | 0.011304 | 0.04944 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.85% (2/108) | 3.64 | 0.011304 | 0.04944 |
GO:0008340 | determination of adult lifespan | 2.78% (3/108) | 2.74 | 0.010384 | 0.049678 |
GO:0005929 | cilium | 2.78% (3/108) | 2.74 | 0.010384 | 0.049678 |
GO:0010228 | vegetative to reproductive phase transition of meristem | 3.7% (4/108) | 2.24 | 0.010444 | 0.049804 |
GO:0046903 | secretion | 3.7% (4/108) | 2.24 | 0.010444 | 0.049804 |
GO:0005654 | nucleoplasm | 10.19% (11/108) | 1.16 | 0.010478 | 0.049882 |